Bragar Eagel & Squire is Investigating Certain Officers and Directors of Mammoth Energy, Acer Therapeutics, Realogy Holdings, and AxoGen and Encourages Investors to Contact the Firm Sep 11, 2019 08:00PM
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Lannett, Molson Coors, AxoGen, and American Renal Associates and Encourages Investors to Contact the Firm Aug 14, 2019 09:02PM
Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of AxoGen (NASDAQ: AXGN) and Encourages AxoGen Investors to Contact the Firm Jul 22, 2019 06:44PM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AxoGen, Markel, Maxar, and Wirecard and Encourages Investors to Contact the Firm Mar 10, 2019 06:00PM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AxoGen, Markel, Maxar, and Wirecard and Encourages Investors to Contact the Firm Mar 3, 2019 06:15PM


Feb 24, 2019 06:08PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AxoGen, Markel, Maxar, and Wirecard and Encourages Investors to Contact the Firm
Feb 17, 2019 01:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AxoGen, Markel, Maxar, and Wirecard and Encourages Investors to Contact the Firm
Feb 10, 2019 04:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Welbilt, AxoGen, Markel, and Maxar and Encourages Investors to Contact the Firm
Jan 31, 2019 09:04PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Welbilt, AxoGen, Markel, and Maxar and Encourages Investors to Contact the Firm
Jan 24, 2019 08:20PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Welbilt, AxoGen, Markel, and Maxar and Encourages Investors to Contact the Firm
Jan 9, 2019 09:00PM Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AxoGen, Inc. (AXGN) and Encourages AXGN Investors to Contact the Firm